Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London
March 30, 2020 08:32 ET
|
RenovaCare, Inc.
ROSELAND, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare Announces New Corporate Headquarters and Laboratory Facilities
March 11, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., March 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced new corporate headquarters in Roseland, New Jersey and laboratory...
CYTOVIA Therapeutics and the New York Stem Cell Foundation Research Institute enter into a partnership to develop iPSC derived CAR NK Therapeutics
January 09, 2020 08:00 ET
|
Cytovia Therapeutics
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The New York Stem Cell Foundation (NYSCF) Research Institute today announced a partnership with Cytovia Therapeutics Inc. (Cytovia) to develop new disease...
BioCardia Announces New U.S. Patent Covering CardiAMP Cell Therapy and Issuance of Two Asian Patents Covering Radial Artery Approach for Cardiac Cell and Gene Therapy Delivery
January 08, 2020 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Jan. 08, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioRestorative Therapies Featured in IEEE Pulse Magazine’s Cover Story About Stem Cell Therapies for Low Back Pain
December 16, 2019 08:00 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program
December 12, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 12, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
RenovaCare Stockholder Update and 2020 Outlook from the CEO
December 05, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Dec. 05, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other...
Dr. Emanual Maverakis, Recipient of Presidential Award for Scientists and Engineers, Joins RenovaCare
November 26, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Nov. 26, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
BioCardia Reports 2019 Third Quarter Financial Results and Business Highlights
November 19, 2019 17:24 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
RenovaCare Appoints Alan L. Rubino as President and CEO
November 18, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Nov. 18, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...